# RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas

> **NCT07661043** · NA · NOT_YET_RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 50 (estimated)

## Conditions studied

- Fistula
- Regenerative Medicine
- Stromal Vascular Fraction

## Interventions

- **PROCEDURE:** Endoscopic tSVF-EM Therapy

## Key facts

- **NCT ID:** NCT07661043
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07661043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07661043, "RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07661043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*